References
- Barber, D. S., J. Hunt, R. M. LoPachin, and M. Ehrich. 2001. “Determination of Acrylamide and Glycidamide in Rat Plasma by Reversed-Phase High Performance Liquid Chromatography.” Journal of Chromatography B: Biomedical Sciences and Applications 758 (2): 289–293. doi:10.1016/S0378-4347(01)00191-8.
- Barber, D. S., J. R. Hunt, M. F. Ehrich, E. J. Lehning, and R. M. LoPachin. 2001. “Metabolism, Toxicokinetics and Hemoglobin Adduct Formation in Rats following Subacute and Subchronic Acrylamide Dosing.” NeuroToxicology 22 (3): 341–353. doi:10.1016/S0161-813X(01)00024-9.
- Demirci, B., O. Demir, T. Dost, and M. Birincioglu. 2014. “Protective Effect of Vitamin B5 (Dexpanthenol) on Cardiovascular Damage Induced by Streptozocin in Rats.” Bratislavske Lekarske Listy 115 (4): 190–196. doi:10.4149/bll_2014_040
- Doerge, D. R., J. F. Young, L. P. McDaniel, N. C. Twaddle, and M. I. Churchwell. 2005a. “Toxicokinetics of Acrylamide and Glycidamide in B6C3F1 Mice.” Toxicology and Applied Pharmacology 202 (3): 258–267. doi:10.1016/j.taap.2004.07.001
- Doerge, D. R., J. F. Young, L. P. McDaniel, N. C. Twaddle, and M. I. Churchwell. 2005b. “Toxicokinetics of Acrylamide and Glycidamide in Fischer 344 Rats.” Toxicology and Applied Pharmacology 208 (3): 199–209. doi:10.1016/j.taap.2005.03.003
- Doroshyenko, O., U. Fuhr, D. Kunz, D. Frank, M. Kinzig, A. Jetter, Y. Reith, et al. 2009. “In Vivo Role of Cytochrome P450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans.” Cancer Epidemiology, Biomarkers & Prevention 18 (2): 433–443. doi:10.1158/1055-9965.EPI-08-0832
- Dostalek, M., F. Akhlaghi, and M. Puzanovova. 2012. “Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs.” Clinical Pharmacokinetics 51 (8): 481–499. doi:10.2165/11631900-000000000-00000.
- Gamboa da Costa, G., M. I. Churchwell, L. P. Hamilton, L. S. Von Tungeln, F. A. Beland, M. M. Marques, and D. R. Doerge. 2003. “DNA Adduct Formation from Acrylamide via Conversion to Glycidamide in Adult and Neonatal Mice.” Chemical Research in Toxicology 16 (10): 1328–1337. doi:10.1021/tx034108e
- Gonzales, G. F., C. Maldonado, and L. Xu. 2015. “Extracts of Black Maca Reduces Glycemia on Streptozotocin-Induced Diabetes in Male Rats and Reduces Insulin Resistance (IR) in HepG2 Cell Line in Vitro.” Poster presented at the annual meeting for the Society of Endocrine, San Diego, March 5-8.
- Herder, C., M. Karakas, and W. Koenig. 2011. “Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease.” Clinical Pharmacology and Therapeutics 90 (1): 52–66. doi:10.1038/clpt.2011.93
- Karimani, A., H. Hosseinzadeh, S. Mehri, A. H. Jafarian, S. A. Kamali, A. H. Mohammadpour, and G. R. Karimi. 2021. “Histopathological and Biochemical Alterations in Non-Diabetic and Diabetic Rats following Acrylamide Treatment.” Toxin Reviews 40 (3): 277–284. doi:10.1080/15569543.2019.1566263.
- Kim, Y. C., A. K. Lee, J. H. Lee, I. Lee, D. C. Lee, S. H. Kim, S. G. Kim, and M. G. Lee. 2005. “Pharmacokinetics of Theophylline in Diabetes Mellitus Rats: Induction of CYP1A2 and CYP2E1 on 1,3-Dimethyluric Acid Formation.” European Journal of Pharmaceutical Sciences 26 (1): 114–123. doi:10.1016/j.ejps.2005.05.004
- Massart, J., K. Begriche, and B. Fromenty. 2021. “Cytochrome P450 2E1 Should Not Be Neglected for Acetaminophen-Induced Liver Injury in Metabolic Diseases with Altered Insulin Levels or Glucose Homeostasis.” Clinics and Research in Hepatology and Gastroenterology 45 (1): 101470. doi:10.1016/j.clinre.2020.05.018
- Mirzaei, M., M. Rahmaninan, M. Mirzaei, A. Nadjarzadeh, and A. A. Dehghani tafti. 2020. “Epidemiology of Diabetes Mellitus, Pre-Diabetes, Undiagnosed and Uncontrolled Diabetes in Central Iran: Results from Yazd Health Study.” BMC Public Health 20 (1): 166. doi:10.1186/s12889-020-8267-y.
- Jayachandran M, Vinayagam R, Ambati RR, Xu B, Chung SSM. 2018. “Guava Leaf Extract Diminishes Hyperglycemia and Oxidative Stress, Prevents β-Cell Death, Inhibits Inflammation, and Regulates NF-kB Signaling Pathway in STZ Induced Diabetic Rats.” BioMed Research International 2018: 4601649. doi:10.1155/2018/4601649
- Parzefall, W. 2008. “Minireview on the Toxicity of Dietary Acrylamide.” Food and Chemical Toxicology 46 (4): 1360–1364. doi:10.1016/j.fct.2007.08.027.
- Rosén, J, and K. E. Hellenäs. 2002. “Analysis of Acrylamide in Cooked Foods by Liquid Chromatography Tandem Mass Spectrometry.” The Analyst 127 (7): 880–882. doi:10.1039/B204938D
- Sindhu, R. K., J. R. Koo, K. K. Sindhu, A. Ehdaie, F. Farmand, and C. K. Roberts. 2006. “Differential Regulation of Hepatic Cytochrome P450 Monooxygenases in Streptozotocin-Induced Diabetic Rats.” Free Radical Research 40 (9): 921–928. doi:10.1080/10715760600801272
- Tareke, E., P. Rydberg, P. Karlsson, S. Eriksson, and M. Törnqvist. 2002. “Analysis of Acrylamide, a Carcinogen Formed in Heated Foodstuffs.” Journal of Agricultural and Food Chemistry 50 (17): 4998–5006. doi:10.1021/jf020302f.
- Wang, Z., S. D. Hall, J. F. Maya, L. Li, A. Asghar, and J. C. Gorski. 2003. “Diabetes Mellitus Increases the in Vivo Activity of Cytochrome P450 2E1 in Humans.” British Journal of Clinical Pharmacology 55 (1): 77–85. doi:10.1046/j.1365-2125.2003.01731.x.
- WHO (World Health Organization). 2016. Global Report on Diabetes. Geneva: WHO Press.